Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

25% of COVID-19 patients have lasting reduction in lung function

25% of COVID-19 patients have lasting reduction in lung function

28 Feb 2023
Mass spectrometry-based identification of COVID-19 biomarkers

Mass spectrometry-based identification of COVID-19 biomarkers

28 Feb 2023
The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

28 Feb 2023
COVID-19 does not increase the risk of Streptococcus pneumoniae infection

COVID-19 does not increase the risk of Streptococcus pneumoniae infection

28 Feb 2023
Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

28 Feb 2023
COVID-19 increases risk of developing chronic diseases

COVID-19 increases risk of developing chronic diseases

28 Feb 2023
A review of respiratory viruses monitored in wastewater samples

A review of respiratory viruses monitored in wastewater samples

28 Feb 2023
The evolution of transmissible variants harboring mutations consistent with immune escape in mild community COVID-19 cases

The evolution of transmissible variants harboring mutations consistent with immune escape in mild community COVID-19 cases

28 Feb 2023
Can the gut microbiota and metabolome explain variation in anti-SARS-CoV-2 vaccination responses in immunosuppressed IBD patients?

Can the gut microbiota and metabolome explain variation in anti-SARS-CoV-2 vaccination responses in immunosuppressed IBD patients?

27 Feb 2023
Does a negative COVID-19 test before air travel reduce the spread of COVID-19 transmission during and after travel?

Does a negative COVID-19 test before air travel reduce the spread of COVID-19 transmission during and after travel?

27 Feb 2023
High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

27 Feb 2023
Study shows COVID-19 rates were likely forty-times higher than CDC estimates during BA.4/BA.5 dominant period in the U.S.

Study shows COVID-19 rates were likely forty-times higher than CDC estimates during BA.4/BA.5 dominant period in the U.S.

27 Feb 2023
Rebounding of COVID-19 symptoms and viral load are common among untreated COVID-19 patients

Rebounding of COVID-19 symptoms and viral load are common among untreated COVID-19 patients

27 Feb 2023
How the delivery of family-centered care practices were impacted for neonates born to mothers with perinatal SARS-CoV-2 infection during the COVID-19 pandemic

How the delivery of family-centered care practices were impacted for neonates born to mothers with perinatal SARS-CoV-2 infection during the COVID-19 pandemic

24 Feb 2023
Roadmap outlines a framework for moving COVID-19 vaccines forward

Roadmap outlines a framework for moving COVID-19 vaccines forward

24 Feb 2023
Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

24 Feb 2023
Study highlights COVID-19 vaccine safety among children

Study highlights COVID-19 vaccine safety among children

23 Feb 2023
Following third dose of BNT162b2, adverse events increased in those with prior COVID-19

Following third dose of BNT162b2, adverse events increased in those with prior COVID-19

23 Feb 2023
Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine?

Is the advantage conferred by the heterologous regimen conserved after a booster dose of mRNA-based COVID-19 vaccine?

23 Feb 2023
The role of pre-infection sleep quality/duration and insomnia severity in the incidence of long-term symptoms after COVID-19

The role of pre-infection sleep quality/duration and insomnia severity in the incidence of long-term symptoms after COVID-19

23 Feb 2023

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback